Close Menu
August 28, 2019
Sponsored by
Horizon Discovery

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases


Director of the Center for Advance Genome Engineering,
St. Jude Children’s Research Hospital

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Genome editing using the CRISPR-Cas9 platform enables precise genetic manipulations within complex genomes. Although wild-type Streptococcus pyogenes Cas9 (SpCas9) was the first detailed CRISPR platform, this widely used nuclease is still limited by the canonical 5’-NGG-3’ protospacer adjacent motif required for SpCas9 binding and cleavage.

In this webinar, Shondra Miller of St. Jude Children's Research Hospital will discuss the pros and cons of several Cas9 variants and orthologues and how these alternative nucleases can be applied to genome editing workflows.

Sponsored by

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Sponsored by

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Sponsored by

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.